GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (BSP:A1RG34) » Definitions » Unearned Income

argenx SE (BSP:A1RG34) Unearned Income


View and export this data going back to 2020. Start your Free Trial

What is argenx SE Unearned Income?

Unearned Income only applies to banks.


argenx SE (BSP:A1RG34) Business Description

Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.